Danaher Co. (NYSE:DHR) Shares Bought by FFT Wealth Management LLC

FFT Wealth Management LLC grew its holdings in shares of Danaher Co. (NYSE:DHR) by 25.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,300 shares of the conglomerate’s stock after purchasing an additional 676 shares during the period. FFT Wealth Management LLC’s holdings in Danaher were worth $758,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the fourth quarter valued at $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher in the fourth quarter valued at $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher in the fourth quarter worth $31,000. Teachers Insurance & Annuity Association of America purchased a new stake in Danaher in the 3rd quarter worth about $39,000. Finally, MidAtlantic Capital Management Inc. acquired a new stake in Danaher during the 3rd quarter worth about $40,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 0.2 %

Danaher stock opened at $210.65 on Wednesday. The firm has a market cap of $150.56 billion, a price-to-earnings ratio of 39.90, a P/E/G ratio of 2.66 and a beta of 0.83. The firm has a fifty day moving average price of $225.79 and a two-hundred day moving average price of $246.04. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the firm posted $2.09 earnings per share. As a group, analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. Danaher’s dividend payout ratio (DPR) is presently 24.24%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by insiders.

Analysts Set New Price Targets

DHR has been the subject of a number of research reports. The Goldman Sachs Group set a $250.00 target price on shares of Danaher in a research note on Wednesday, January 15th. Raymond James restated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research report on Friday, December 13th. Wells Fargo & Company reduced their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Finally, Jefferies Financial Group dropped their price objective on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. Seven research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.